XELJANZ / XELJANZ XR (tofacitinib) Health Professional Information

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

SUMMARY PRODUCT INFORMATION

Route of Administration

Dosage Form / Strength

Clinically Relevant Nonmedicinal Ingredients

Oral

Tofacitinib tablets / 5 mg tofacitinib and 10 mg (as tofacitinib citrate)

Tofacitinib extended-release tablets / 11 mg tofacitinib (as tofacitinib citrate)

For a complete listing see Dosage Forms, Composition and Packaging section.